Seed · Healthtech · Tallinn, Estonia · Founded 2021 · 11–50 employees
DrugCards develops an AI-powered SaaS and data intelligence platform designed to automate pharmacovigilance and drug safety processes. The platform automates medical literature screening, regulatory intelligence monitoring, and adverse event tracking to reduce manual literature screening time by up to 70%. By scanning over 2,200 local and global medical journals across more than 100 languages, it helps pharmaceutical companies and contract research organizations identify adverse drug reactions. The company has demonstrated market traction by securing partnerships with pharmaceutical company Farmak and raising venture capital from European and Ukrainian investment groups.